CompletedPhase 4

IM Neostigmine for Accelerating Bladder Emptying After CS by Spinal Anesthesia

Egypt100 participantsStarted 2020-08-05

Plain-language summary

The aim of this study is to assess the efficacy of IM neostigmine (0.5 mg) for acceleration of bladder evacuation and prevention of postoperative urine retention following cesarean delivery carried out under spinal anesthesia

Who can participate

Age range

20 Years – 35 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women undergoing elective cesarean deliver under spinal anesthesia. Exclusion Criteria: * The age of the patient is more than 35 years of less than 20 years. * The body mass index of the patient is more than 35 kg/m2 or her height is more than 180 cm or less than 150 cm. * Multiple gestation. * The patient is in active labor. * Vaginal bleeding, placenta previa or abruption of the placenta. * Presence of fetal distress. * Urinary symptoms. * Medical disorders co-existing with or complicating pregnancy. * Contraindications for or history of adverse reaction of Neostigmine. * Contraindication for spinal anesthesia. * Refusal of the patient to receive spinal anesthesia. * Intraoperative significant hemorrhage. * Duration of the operation is more than one hour. * Occurrence of postoperative complications as eclampsia.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Time to first voiding after treatment

Timeframe: Until 12 hours postoperatively

Time to first voiding after catheter removal

Timeframe: Until 12 hours postoperatively

Trial details

NCT IDNCT04364607

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-10-26

View on ClinicalTrials.gov More Cesarean Section Complications trials